- Home
- BHAT vs MIRA Comparison
BHAT vs MIRA Comparison
Compare BHAT & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- MIRA
- Stock Information
- Founded
- BHAT 2010
- MIRA 2020
- Country
- BHAT China
- MIRA United States
- Employees
- BHAT N/A
- MIRA N/A
- Industry
- BHAT Recreational Games/Products/Toys
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- MIRA Health Care
- Exchange
- BHAT Nasdaq
- MIRA Nasdaq
- Market Cap
- BHAT 14.5M
- MIRA 17.1M
- IPO Year
- BHAT 2019
- MIRA 2023
- Fundamental
- Price
- BHAT $0.19
- MIRA $1.52
- Analyst Decision
- BHAT
- MIRA Strong Buy
- Analyst Count
- BHAT 0
- MIRA 2
- Target Price
- BHAT N/A
- MIRA $14.00
- AVG Volume (30 Days)
- BHAT 431.4K
- MIRA 3.6M
- Earning Date
- BHAT 12-20-2024
- MIRA 11-12-2024
- Dividend Yield
- BHAT N/A
- MIRA N/A
- EPS Growth
- BHAT N/A
- MIRA N/A
- EPS
- BHAT N/A
- MIRA N/A
- Revenue
- BHAT $73,686,733.00
- MIRA N/A
- Revenue This Year
- BHAT N/A
- MIRA N/A
- Revenue Next Year
- BHAT N/A
- MIRA N/A
- P/E Ratio
- BHAT N/A
- MIRA N/A
- Revenue Growth
- BHAT 3255.57
- MIRA N/A
- 52 Week Low
- BHAT $0.17
- MIRA $0.51
- 52 Week High
- BHAT $1.45
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- BHAT 32.17
- MIRA 48.79
- Support Level
- BHAT $0.17
- MIRA $1.42
- Resistance Level
- BHAT $0.24
- MIRA $1.75
- Average True Range (ATR)
- BHAT 0.03
- MIRA 0.29
- MACD
- BHAT -0.00
- MIRA -0.04
- Stochastic Oscillator
- BHAT 19.57
- MIRA 7.02
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.